These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Behavior of serum triiodothyronine in subjects treated with I-131 for hyperthyroidism]. Bagnasco M; Biassoni P; Clemente GF; Vibracci G; Ferrini O Arch Maragliano Patol Clin; 1975; 31(1):77-87. PubMed ID: 1244069 [No Abstract] [Full Text] [Related]
24. [On the radioiodine diagnosis of the autonomous adenoma of the thyroid gland]. Petersen F; van der Heide A Strahlentherapie; 1966 Dec; 131(4):520-8. PubMed ID: 4171006 [No Abstract] [Full Text] [Related]
25. The changes in the thyroid gland after irradiation with 131I or partial thyroidectomy for thyrotoxicosis. Kennedy JS; Thomson JA J Pathol; 1974 Feb; 112(2):65-81. PubMed ID: 4834051 [No Abstract] [Full Text] [Related]
28. [Functional state of the thyroid gland in adenomas of the hypophysis]. Shurygin DIa; Popov SE; Komarova TF; Murchakova AF; Sokolova EV Probl Endokrinol (Mosk); 1967; 13(1):11-5. PubMed ID: 4186722 [No Abstract] [Full Text] [Related]
29. [Autonomic thyroid adenoma and cold nodule--active therapy or wait-and-see observation? Conservative therapy]. Horster FA Internist (Berl); 1979 Mar; 20(3):142-6. PubMed ID: 372120 [No Abstract] [Full Text] [Related]
30. Blood dosimetry and dose-rate effects after radioiodine therapy of differentiated thyroid cancer. Lassmann M; Luster M; Hänscheid H; Reiners C J Nucl Med; 2005 May; 46(5):899. PubMed ID: 15872368 [No Abstract] [Full Text] [Related]
31. [The prospects for using x-ray fluorescent analysis in vivo in the diagnosis of thyroid diseases]. TomashevskiÄ IO; Tsitsiashvili BSh Probl Endokrinol (Mosk); 1988; 34(6):86-93. PubMed ID: 3070540 [No Abstract] [Full Text] [Related]
32. [How does it function? Radioiodine therapy]. Schicha H MMW Fortschr Med; 2003 Oct; 145(42):71-2. PubMed ID: 14655457 [No Abstract] [Full Text] [Related]
33. Radioiodine or surgery for toxic thyroid adenoma: dissecting an important decision. A cost-effectiveness analysis. Vidal-Trecan GM; Stahl JE; Eckman MH Thyroid; 2004 Nov; 14(11):933-45. PubMed ID: 15671772 [TBL] [Abstract][Full Text] [Related]
35. The role of radioactive iodine in the treatment of well-differentiated thyroid cancer. Weigel RJ; McDougall IR Surg Oncol Clin N Am; 2006 Jul; 15(3):625-38. PubMed ID: 16882501 [TBL] [Abstract][Full Text] [Related]
36. [Discrepancy between peripheral thyroid hormone values and TSH level]. Heinze HG Dtsch Med Wochenschr; 1995 Nov; 120(47):1639-40. PubMed ID: 7493567 [No Abstract] [Full Text] [Related]
37. A randomized trial of remnant ablation--in search of an impossible dream? Mazzaferri E J Clin Endocrinol Metab; 2004 Aug; 89(8):3662-4. PubMed ID: 15292283 [No Abstract] [Full Text] [Related]
38. Radiation exposure to the family of radioactive patients. Harbert JC; Wells N J Nucl Med; 1974 Oct; 15(10):887-8. PubMed ID: 4418007 [No Abstract] [Full Text] [Related]
39. [Iodine, iodine-131 and the problems of thyroidology]. Tron'ko ND; Markov VV; Kashkadamov AV; Terek OV Probl Endokrinol (Mosk); 1989; 35(6):87-90. PubMed ID: 2695920 [No Abstract] [Full Text] [Related]
40. Applying the radioactive eraser: I-131 to ablate normal thyroid tissue in patients from whom thyroid cancer has been resected. Sisson JC J Nucl Med; 1983 Aug; 24(8):743-5. PubMed ID: 6875686 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]